Analyst Ratings for Aardvark Therapeutics Inc (AARD)
AARD Rating Summary
AARD Price Target Summary
- Highest: $50.00 (Cantor Fitzgerald)
- Lowest: $6.00 (RBC Capital)
- Average: $23.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$23.20 (+296.6%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$23.20 (+296.6%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/2/2026 | H.C. Wainwright | Raghuram Selvaraju | Downgrade | Neutral (Buy) |
N/A (N/A) |
12.49 (5.85) |
-53.16% | Details |
| 3/2/2026 | Stifel | James Condulis | Downgrade | Hold (Buy) |
6.00 (24.00) |
12.50 (5.85) |
-53.2% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
